Skip to main content
TipRanks
Go Ultimate75% OFF

Recovery International Co.,Ltd. (9214) AI Stock Analysis

0 Followers
JP:9214

Recovery International Co.,Ltd.

(TSE/TYO:9214)

Select Model
Rating:65Neutral
Price Target:JPY 1,352.00â–²(6.04% Upside)
Action:reiterated
Date:11/08/26

The overall score of 65 is anchored by the company's strong balance sheet, consistent top-line growth, and an attractive P/E valuation of 15.3. However, the score is heavily weighed down by weak technical momentum, as the stock trades below all major moving averages, and underlying fundamental risks tied to recent margin compression and declining cash flow efficiency. Investors should monitor whether the company can stabilize its profit margins to support future price appreciation.

Positive Factors
Sustained Revenue GrowthConsistent multi-year revenue expansion indicates that the company has continued to increase its operating scale. Growth remaining healthy in 2025, despite a tougher comparison, supports ongoing demand and provides a foundation for future profit generation and reinvestment.
Negative Factors
2025 Margin PressureThe decline in net income while revenue increased shows that growth did not translate proportionally into earnings in 2025. Lower operating and net margins may reflect rising costs or investment spending, creating a durable risk to profit growth if the pressure persists.

Recovery International Co.,Ltd. (9214) vs. iShares MSCI Japan ETF (EWJ)

-20%-10%0%10%20%30%JP:9214-10.21%EWJ+14.66%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 1.66B
Dividend Yield
―
Average Volume (3M)
1,689
Price to Earnings (P/E)
12.5
Beta (1Y)
0.45
Revenue Growth
27.36%
EPS Growth
22.17%
Country
Japan
Employees
280
Sector
General
Sector Strength
55
Industry
Medical - Care Facilities

Recovery International Co.,Ltd. Business Overview & Revenue Model

Company Description

Based in Shinjuku-Ku, Japan, and incorporated in 2013, Recovery International Co.,Ltd. delivers a range of in-home care and rehabilitation services throughout Japan. The company offers domiciliary nursing support to individuals grappling with illness...

Recovery International Co.,Ltd. Financial Statement Overview

Summary

Financial performance reflects a solid foundation with robust revenue growth and a very healthy balance sheet marked by low leverage and rising equity. However, the score is tempered by recent margin compression leading to declining net income, as well as a noticeable drop in cash flow conversion efficiency.

Income Statement

78Positive

Balance Sheet

85Very Positive

Cash Flow

60Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue2.69B2.69B2.04B1.61B1.39B1.12B
Gross Profit1.16B1.15B855.68M640.22M536.81M451.77M
EBITDA212.51M215.18M186.16M157.61M164.71M150.12M
Net Income127.71M127.71M145.73M110.14M108.30M100.86M
Balance Sheet
Total Assets1.35B1.35B1.04B901.58M784.23M474.80M
Cash, Cash Equivalents and Short-Term Investments587.20M587.20M509.38M524.10M451.81M203.00M
Total Debt177.84M177.84M017.35M40.13M66.46M
Total Liabilities573.56M573.56M329.91M246.84M239.53M245.36M
Stockholders Equity774.37M774.37M708.02M654.74M544.69M229.44M
Cash Flow
Free Cash Flow065.61M115.53M109.02M78.39M98.61M
Operating Cash Flow070.75M119.56M114.81M87.70M101.01M
Investing Cash Flow0-70.83M-23.68M-19.64M9.57M-24.34M
Financing Cash Flow077.90M-110.60M-22.87M171.54M-18.25M

Recovery International Co.,Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price1275.00

Price Trends

50DMA1279.82Negative
100DMA1275.50Negative
200DMA1323.86Negative

Market Momentum

MACD4.17Negative
RSI47.20Neutral
STOCH62.24Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9214, the sentiment is Negative. The current price of 1275.00 is above the 20-day moving average (MA) of 1273.05, below the 50-day MA of 1279.82, and below the 200-day MA of 1323.86, indicating a bearish trend. The MACD of 4.17 indicates Negative momentum. The RSI at 47.20 is Neutral, neither overbought nor oversold. The STOCH value of 62.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:9214.

Recovery International Co.,Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:9214 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:9220JP:922079OutperformJPY 3.06B6.50―3.43%5.71%10.34%
JP:6062JP:606273OutperformJPY 64.01B14.43―2.19%5.50%45.42%
JP:9214JP:921465NeutralJPY 1.80B12.46――27.36%22.17%
JP:2373JP:237361NeutralJPY 5.21B18.21―4.39%4.76%-52.55%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:2425JP:242555NeutralJPY 2.50B28.45―3.34%-3.64%-66.52%
JP:7061JP:706141NeutralJPY 3.16B-31.16――6.75%-119.69%

* General Sector Average

Performance Comparison

-50%0%50%JP:9214JP:2373JP:2425JP:6062JP:7061JP:9220Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:9214 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:9214Recovery International Co.,Ltd.1275.00-133.00-9.45%
JP:2373Care Twentyone Corporation387.00-38.38-9.02%
JP:2425Care Service Co., Ltd.659.00-99.22-13.09%
JP:6062Charm Care Corporation1963.00791.1967.52%
JP:7061Japan Hospice Holdings Inc.373.00-900.14-70.70%
JP:9220FB CARE SERVICE CO.,LTD.1254.0084.077.19%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 07, 2026